Background: There are few recent data on trends in childhood cancer incidence using populationbased cancer registries in Japan. Methods: This study comprised 6110 reported cases of patients aged 0-14 years who were diagnosed as having primary cancer between 1993 and 2009. We chose cancer registries of seven prefectures, according to the international cancer registry standard of fewer than 10% death certificate only cases among cancer registries in Japan. We analyzed population-based cancer registration data in the seven prefectures between 1993 and 2009. We calculated childhood cancer incidence, agespecific incidence, crude incidence rate, age-adjusted incidence rate, confidence intervals and annual change for each prefecture and classified the data into 12 diagnostic groups, according to the International Classification of Childhood Cancer (ICCC). Results: According to sex-specific incidence, males accounted for slightly more cases than females. Children 0-3 years old accounted for 41.1% of patients. Leukemia accounted for 36.0% of cancers, followed by central nervous system tumors with 15.0%, according to the ICCC. The crude incidence rate did not change substantially, remaining at an average 8-11 per 100 000 population. In addition, the age-adjusted incidence rate remained constant with an average 2 per 100 000 population. Conclusions: Using population-based cancer registry data, age-specific incidence and 12 diagnostic groups according to the ICCC showed characteristics of childhood cancers. The incidence rate of childhood cancers has been nearly stable in Japan over the past 15 years.
Introduction
To provide adequate long-term cancer treatment and care it is extremely important to national health planning to develop a basic index, such as cancer incidence, patient behavior and prognosis. Population-based cancer registries are used worldwide to estimate these indexes. Childhood cancers are rare and there are few patients; therefore, there are few available analyses and investigations of these data in Japan. The National Cancer Registry and Japan Childhood Cancer Registry have recently begun the work of data collection in the country. However, it will take more than 5 years until these registration systems are fully optimized and data collection can be considered reliable and complete.
In an effort to collect sufficient data on childhood cancer incidence, we obtained long-term data from multiple population-based cancer registries to estimate incidence and to classify these data into 12 diagnostic groups according to the International Classification of Childhood Cancer (ICCC). Using these data, we carried out descriptive epidemiological analysis, to investigate current trends of childhood cancer in Japan.
Methods
In our study, death certificate only (DCO) was used to evaluate the accuracy of cancer registrations in Japan. We chose to use the international standard of fewer than 10% DCO registrations. We analyzed childhood cancer cases between 1993 and 2009 using data obtained from population-based cancer registries in seven prefectures throughout the country: Yamagata, Niigata, Fukui, Aichi, Osaka, Okayama and Nagasaki. For each prefecture, primary cancer incidence age was extracted for patients under 15 years old. This study excluded cancers that were classified as benign, uncertain benign or malignant, and carcinoma in situ for which convalescence was relatively good. For cases of multiple cancers, we extracted primary cancer data only, for 1993-2009.
Many types of epithelial carcinoma occur in adults; however, sarcomas and blastomas derived from precursor cells are more common in children than in adults. Thus, it is difficult to classify childhood cancers according to the International Classification of Diseases (ICD-10). We therefore categorized childhood cancers using the ICCC, which classifies tumors into 12 main groups. This study calculated childhood cancer incidence, annual change, sexand age-specific incidence, and classified into 12 diagnostic groups according to the ICCC. Table 1 shows all cancer incidence, childhood cancer incidence, and DCO cases for each of the prefectures investigated. There were a total 1 639 101 cases of all cancers and 6110 cases of childhood cancers in the seven prefectures.
Childhood cancer incidence, 1993-2009
To calculate sex-and age-specific incidence for all prefectures, childhood cancer incidence was classified by age, from 0 to 14 years old.
Many types of epithelial carcinoma occur among adults, however, childhood cancer occurs the most common sarcoma and blastoma derived from precursor cells. Thus, it is difficult to classify childhood cancers according to the International Classification of Diseases (ICD-10). Therefore, we categorized childhood cancers using the ICCC, which classifies tumors into 12 main groups.
The crude incidence rate was determined using childhood cancer incidence calculated from population-based cancer registries and child population data from cancer registration statistics of the National Cancer Center information service (1).
The crude incidence rate may contain bias because there are differences in the age structure by prefecture. Therefore, groups of different age structures can be more accurately compared using age-adjusted incidence rate. The age-adjusted incidence rate was calculated by a direct method using the standard population (corrected population based on the national population census of 1985).
Estimation of 95% confidence intervals (CIs) for cancer incidence rate is expressed by the following formula:
n is the population size, R the sample rate and p the population rate.
Results Figure 1 shows age-and sex-specific childhood cancer incidence. According to sex-specific incidence, males accounted for slightly more cases than females. Children aged 0 years had the highest agespecific incidence. This trend decreased in children older than 0 years, but higher cancer incidence persisted up to 3 years of age. The lowest incidence was among children 9 years old; however, a gradually increasing trend was seen after 10 years of age. Figure 2 shows the ICCC categories. Leukemia, myeloproliferative diseases and myelodysplastic diseases were the most common, accounting for 36.0% of cases. This was followed by 15.0% of cases with central nervous system tumors (CNS) and miscellaneous intracranial and intraspinal neoplasms. The third most common category was neuroblastoma and other peripheral nervous cell tumors, with 11.0% of cases. The next two categories were lymphoma and reticuloendothelial system neoplasms (9.7%), and germ cell tumors, trophoblastic tumors and neoplasms of the gonads (6.4%). Figure 3 shows crude incidence rate and age-adjusted incidence rate for childhood cancer, with 95% CIs, from 1993 to 2009. The average crude incidence rate was 10.13 per 100 000 population and the average age-adjusted incidence rate 2.12 per 100 000 population. The crude incidence rate was around 10-11 cases per 100 000 population and age-adjusted incidence rate remained at~2 per 100 000 population. 
Discussion and conclusions
This study aimed to clarify the general trend of childhood cancer in Japan, using population-based cancer registries of seven prefectures. The highest age-specific incidence was in children 0-3 years old. It has been discussed that some childhood cancers may be related to genetic factors (2) . In addition, children with hereditary diseases, such as immunodeficiency and genetic disorders (for example, Down syndrome), are more likely to develop cancer during childhood (3). In adults, cancer is strongly related to environmental factors including alcohol consumption, cigarette smoking, and lifestyle (4). Many childhood cancers are contracted at a young age; it is unlikely that they are related to environmental factors. However, Figure 1 . Age-and sex-specific childhood cancer incidence in all seven prefectures. there are many arguments about environmental factors or genetic it. In this study, from population-based cancer registration data, it would be considered that one of childhood cancer characteristic has appeared. Other than those above, cancer incidence gradually increased beginning at around 9 years of age; further research is needed on why this is the case.
According to ICCC categories, the highest incidence was for leukemia, followed by brain tumors, neuroblastomas and lymphomas. A concerning high incidence of germ cell tumors, trophoblastic tumors and gonadal tissue neoplasms was also evident; this agrees well with previous studies (5-7) .
The child population has been continually decreasing in Japan, reaching less than 3.5 million in 2002. However, the crude incidence rate for childhood cancers did not show substantial change over the study period, remaining at an average of~8-11 per 100 000 population. On the other hand, the age-adjusted incidence rate remained at an average of 2 per 100 000 population. Previous study reported that incidence of childhood cancer in Japan is~10 per 100 000 population (5). In addition, the incidence of rare cancers are under 6 per 100 000 population (8) . Our results approached these values.
The incidence rate remained constant each year during the study period, despite a decline in the child population. This is generally considered to be a feature of childhood cancer and for this reason, much investigation remains to be carried out. We consider our results can help to lead the move toward future advances in childhood cancer research.
There were several limitations to this study, primarily the use of population-based cancer registration data. Childhood cancer is difficult to diagnose because the affected cells are immature. Few specialists can accurately diagnose these cancers in a timely manner, and there is a shortage of medical institutions for the treatment and care of children with cancer in Japan. It is therefore difficult to stabilize the cancer registry data. Furthermore, children often move from one area of the country to another, which can make it impossible to follow them. To improve the quality of cancer registry data, some problems unique to childhood cancers must be resolved, such as by centralizing services for the treatment and care of children with cancer in Japan.
